USA
News & Media
Take a closer look at what we’re doing across Teva worldwide
Press releases
Oct 21 / 2020
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio
Oct 7 / 2020
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfrm) Injection Published in Headache
Oct 2 / 2020
Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) and ATRIPLA® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) Tablets in the U.S.
Oct 1 / 2020
Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020
Top Stories
Read the latest Teva news
02/Oct/2020
Our Commitment to HIV
For years, Teva has supported patients living with HIV and we continue to do so by delivering quality, cost-effective treatment options to patients. Let’s look at some facts.
29/Sep/2020
Global Diversity Awareness Month
Teva is commemorating Diversity Awareness Month by sharing perspectives from our Employee Resource Group (ERG) leadership
22/Sep/2020
Meet the Expert – Mike Smith, Associate Director for Global Principal Technology
“I used to design telephones but I find this far more rewarding”
